Kalydeco is a prescription therapy used for certain people with cystic fibrosis who have specific genetic mutations. The treatment is designed to help improve the function of a protein involved in salt and fluid movement in the body. Patients using Kalydeco often require regular medical monitoring, nutritional support, and routine health evaluations.
Kalydeco is a medication commonly prescribed for people living with cystic fibrosis who have certain genetic mutations. The therapy is designed to improve the function of the CFTR protein, which helps regulate the movement of salt and fluids in the body. Proper treatment plans, medical supervision, and patient education are important parts of long term care. Understanding how Kalydeco therapy works can help patients and caregivers manage treatment routines more effectively.